Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
Sergi Casadó-LlombartTarek AjamiMarta Consuegra-FernándezEsther CarrerasFernando ArandaNoelia ArmigerAntonio AlcarazLourdes MengualFrancisco LozanoPublished in: The Prostate (2022)
The results show the impact on PCa aggressiveness and recurrence brought about by gene variants involved in modulation of lymphocyte activation (CD5, CD6) and immune-epithelial cell adhesion (CD166/ALCAM) in PCa aggressiveness and recurrence, thus supporting a role for host immune response in PCa pathophysiology.